University Hospital Limerick

Research site

Ireland Saint Nessan's Road, V94 F858 Dooradoyle, Ireland

1 trial recruiting
Prostate cancer metastatic · Chronic lymphocytic leukaemia · Hormone-refractory prostate cancer
Adult patients

About Specializations

University Hospital Limerick in Dooradoyle, Ireland specialises in clinical trials of conditions such as Prostate cancer metastatic, Chronic lymphocytic leukaemia, Hormone-refractory prostate cancer, and other specialisations. This site conducts important research.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location

Saint Nessan's RoadV94 F858 DooradoyleIreland

Open in maps ↗

Recruiting now: 1 trial
Conditions studied: 3

More sites in Dooradoyle Ireland

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Quick filters

3 clinical trials

Prostate cancer metastatic

Recruiting

Study on the Effectiveness of ADT with or without Darolutamide in Men with Newly Diagnosed Metastatic Prostate Cancer and Limited Functional Ability

InvestigationalNo placebo

Study on the Effectiveness of ADT with or without Darolutamide in Men with Newly Diagnosed Metastatic Prostate Cancer and Limited Functional Ability

InvestigationalNo placebo

Ireland

Participants:18–64 years · 65+ years
Substances:Darolutamide
Sponsor:Unicancer

Contact Research Centre

Chronic lymphocytic leukaemia

Not recruiting

Study Comparing Ibrutinib, Venetoclax, and Obinutuzumab for Untreated Chronic Lymphocytic Leukemia Patients

Registered drugNo placebo

Study Comparing Ibrutinib, Venetoclax, and Obinutuzumab for Untreated Chronic Lymphocytic Leukemia Patients

Registered drugNo placebo

Ireland

Participants:18–64 years · 65+ years
Substances:Ibrutinib
Sponsor:University Of Cologne

Contact Research Centre

Hormone-refractory prostate cancer+1

Not recruiting

Study of Pembrolizumab and Enzalutamide for Patients with Metastatic Castration-Resistant Prostate Cancer

Registered drug

Study of Pembrolizumab and Enzalutamide for Patients with Metastatic Castration-Resistant Prostate Cancer

Registered drug

Ireland

Participants:18–64 years · 65+ years
Substances:Enzalutamide
Sponsor:Merck Sharp & Dohme LLC

Contact Research Centre

Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites